-+ 0.00%
-+ 0.00%
-+ 0.00%

Herantis Pharma launches EU-funded HERMOD project for Parkinson’s drug study

PUBT·11/11/2026 09:18:12
Listen to the news
Herantis Pharma launches EU-funded HERMOD project for Parkinson’s drug study
  • Herantis Pharma launched the €8 million, Horizon Europe-funded HERMOD project to support Phase 2 development of HER-096 for Parkinson's disease.
  • Consortium partners include project coordinator Karolinska University Hospital and Luxembourg Institute of Health.
  • First participant dosing is expected in the first half of 2027, subject to financing and regulatory approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Herantis Pharma Oyj published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.